Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
US Stocks

GNRSU stock down 99.99% on 25 Mar 2026: Greenrose (PNK) $0.000001, liquidity risk

March 25, 2026
4 min read
Share with:

GNRSU stock fell sharply during market hours on 25 Mar 2026, trading at $0.000001 after a -99.99933% one-day move. The Greenrose Holding Company Inc. (GNRSU) is quoted on the PNK exchange in the United States and posted volume 145 shares in the session. This article reviews why the intraday drop matters, ties key financial ratios to the price action, and flags liquidity and delisting risks for investors tracking GNRSU stock.

GNRSU stock intraday snapshot and market context

The Greenrose Holding Company Inc. (GNRSU) is quoted on PNK in USD and traded at $0.000001 on 25 Mar 2026. The session change was -0.149999 or -99.99933%, with volume 145 versus a 50-day average price of $0.15. One-day, one-month and year-to-date moves are all roughly -99.999%, signaling a near-total market repricing.

Sponsored

GNRSU stock fundamentals and valuation metrics

Reported trailing EPS is 3.097 and the reported P/E reads about 0.00000032, a statistical artifact given the current micro price and legacy earnings. Market cap shown is $13 with 12,853,627 shares outstanding. Book value per share is 4.3013, revenue per share TTM 1.5812, and gross margin near 59.05%, which highlights large discrepancies between accounting metrics and market valuation.

GNRSU stock liquidity, technicals and price history

Liquidity is the central issue for GNRSU stock: intraday volume was 145 shares and the year high is $0.151. The 50- and 200-day average prices are both $0.15, which contrasts sharply with the latest trade at $0.000001. Low trade counts and a tiny market cap imply wide spreads and high execution risk for any position in GNRSU stock.

GNRSU stock risks and sector considerations

Greenrose operates in Healthcare, specifically Drug Manufacturers – Specialty & Generic, with cannabis production and processing operations. Sector volatility and regulatory pressure increase risk for thinly traded names. Working capital is deeply negative at -103,434,000.00, and debt metrics show debt/equity 1.5728, underlining funding and solvency concerns that likely drove the sharp price move.

Meyka AI grade, analyst view and GNRSU stock outlook

Meyka AI rates GNRSU with a score out of 100: Score 66.91 | Grade B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector and industry comparisons, financial growth, key metrics, and analyst consensus. There is no formal price-target consensus available. For transparency, we note elevated operational and liquidity risks while recognizing the company’s historical book value per share.

GNRSU stock catalysts, filings and where to find updates

There are no recent public earnings announcements linked to this move in the provided feed. Investors should monitor company filings, OTC market notices and press releases. Official company site and market pages are primary sources: see Greenrose website source and the OTC Markets GNRSU page for trading updates source.

Final Thoughts

Key takeaways: GNRSU stock moved to $0.000001 on 25 Mar 2026 after a -99.99933% decline in market hours. The quoted market cap is $13 and intraday volume was 145, which together signal extreme illiquidity. Meyka AI’s forecast model projects $0.00 as the near-term yearly projection, which implies an approximate -100.00% change versus the current trade. This projection is model-based and not a guarantee. Our grading (Score 66.91, Grade B, Suggestion: HOLD) weighs the mismatch between accounting metrics such as book value per share 4.3013 and the market price, plus sector and liquidity risks. For traders, the priority is execution risk: tiny quoted trades can move price by large percentages and raise the prospect of suspension or delisting. For longer-term investors, confirm recent filings, cash runway and management updates before considering exposure to GNRSU stock. Meyka AI provides this analysis as an AI-powered market analysis platform; forecasts are model-based projections and not financial advice.

FAQs

What caused the GNRSU stock crash on 25 Mar 2026?

The sharp GNRSU stock drop reflects extreme illiquidity, low trade volume and market repricing. Company-level factors include negative working capital, debt levels and sector pressure in cannabis. There were no earnings disclosures listed in the provided feed.

Is GNRSU stock a buy after the decline?

Given GNRSU stock’s tiny market cap, low volume and funding risks, the Meyka AI grade is HOLD. Buyers face execution and delisting risk. Investors should wait for clearer filings or liquidity improvements before adding new positions.

Where can I find official GNRSU stock updates and filings?

Monitor Greenrose’s official site for press releases source and the OTC Markets GNRSU page for trading status and notices source. Check filings and regulatory disclosures before trading.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
Meyka Newsletter
Get analyst ratings, AI forecasts, and market updates in your inbox every morning.
~15% average open rate and growing
Trusted by 10,000+ active investors
Free forever. No spam. Unsubscribe anytime.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask our AI about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)